Erratum to: Invest New Drugs
DOI 10.1007/s10637-009-9316-7
In the original version of this article, two authors are missing. Complete list of authors and affiliation are given here.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at http://dx.doi.org/10.1007/s10637-009-9316-7.
Rights and permissions
Open Access This is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License ( https://creativecommons.org/licenses/by-nc/2.0 ), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
About this article
Cite this article
Ma, B.B., Lui, V.W., Poon, F.F. et al. Erratum to: Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response. Invest New Drugs 28, 361 (2010). https://doi.org/10.1007/s10637-010-9397-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10637-010-9397-3